AXNX Axonics Inc
587
$67.15
$0.23
(0.34%)
| Watchers | 587 |
| 52-Wk Low | $47.59 |
| 52-Wk High | $69.68 |
| Market Cap | $3.44B |
| Volume | 169,932.00 |
| 52-Wk High | $69.68 |
| 52-Wk Low | $47.59 |
Axonics Reports First Quarter 2024 Financial ResultsBusiness Wire • 8 days ago
Axonics, Inc. (Nasdaq: AXNX), a medical technology company that develops and commercializes innovative and minimally invasive products to treat bladder and bowel dysfunction, today reported financial...
Share to Feed
Boston Scientific/Axonics merger to close in 2H24 as FTC seeks more info...
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Axonics Inc (AXNX), where a total of 5,694 contracts have traded so far, representing...
This is a signal that AXNX's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...
Axonics Modulation Technologies (AXNX) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings...
This is a signal that AXNX's price trend could be reversing, and it may be an opportunity to sell the stock or take a defensive position...
Axonics, Inc. (Nasdaq: AXNX) announced that its stockholders have voted today to adopt Axonics merger agreement with Boston Scientific Corporation (NYSE: BSX). According to preliminary voting results...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
Axonics, Inc. (Nasdaq: AXNX) today announced that the Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office has issued written decisions on two Medtronic patents that Axonics...
Axonics, Inc. (NASDAQ:AXNX Get Free Report) was the recipient of a significant growth in short interest in the month of February. As of February 29th, there was short interest totalling...